25K Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Karyopharm Therapeutics Inc

Watchlist Manager

Watchlist

Price: 4.7 EUR -1.67% Market Closed

Market Cap: €547.3m

K	Karyopharm Therapeutics Inc F:25K	US
	Coor Service Management Holding AB F:COE	SE
	Eagle Bancorp Montana Inc NASDAQ:EBMT	US
W	WEC Energy Group Inc DUS:WIC	US

Profitability Summary

Karyopharm Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

96%

Strong 3Y Average Gross Margin

96%

Declining Gross Margin

96% > 96%

Negative Operating Margin

-62%

Negative 3Y Average Operating Margin

-80%

Operating Margin is Increasing

-94% > -62%

Negative Net Margin

-134%

Negative 3Y Average Net Margin

-84%

Declining Net Margin

-107% > -134%

Negative Free Cash Flow Margin

-52%

Negative 3Y Average Free Cash Flow Margin

-74%

Free Cash Flow Margin is Increasing

-74% > -52%

Exceptional ROE

82%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-207%

Declining ROIC

-196% > -199%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.